Diagnostic Device Development Suppliers In North America

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for ...

Allergenis is developing precision diagnostic solutions to help healthcare providers and patients better understand and manage their food allergies. Specializing in immunology and bioinformatics, we created a highly multiplexed analytical platform ...

Chembio is a leading diagnostics company focused on developing and commercializing point-of-care tests used to detect and diagnose infectious diseases, including sexually transmitted disease, insect vector and tropical disease, COVID-19 and other ...

Our journey began in 2010, when the earliest team members began to explore the idea of a diagnostic test that could be used by anyone, anywhere. Click Diagnostics explores a number of markets and identifies sexual health as the direction to pursue. ...

Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...

Established in 1989 to develop the world's first PC ECG/PC EKG, Nasiff Associates, a Medical Technology Company, is committed to providing innovative Medical PC Solutions to Health Care Professionals by developing Medical Diagnostic and ...

A champion of life sciences research for more than 30 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, ...

Cairn Diagnostics is a specialized, innovative technology company focused on pioneering, manufacturing, validating and obtaining FDA-approvals for novel breath tests intended for routine use in diagnostic medicine. Cairn develops orally administered ...

Cognoptix is developing a simple, innovative, non-invasive beta amyloid eye scanning test for use in adult patients being evaluated for Alzheimer’s Disease to aid in early diagnosis of this complex and devastating ...

DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...

Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...

For more than 50 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood ...

Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...

Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...

Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...

We are a global biomedical technology company that offers advanced in-vitro diagnostic solutions. We develop, patent, manufacture and market IVD products. Our primary research and development focus is on gastrointestinal and inflammatory diseases ...

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...

Stelvio Oncology utilizes an image based method of epigenetic markers to develop predictive diagnostics and novel therapeutics for cancer. Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Our team has core ...

At Phoresa, we are developing clinical diagnostics that will improve patient care, reduce physician resource strain, and save money for payers. Our disruptive diagnostic technology will allow patients to be tested and treated for infectious diseases ...